1. Home
  2. ITOS vs BRBS Comparison

ITOS vs BRBS Comparison

Compare ITOS & BRBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • BRBS
  • Stock Information
  • Founded
  • ITOS 2011
  • BRBS 1893
  • Country
  • ITOS United States
  • BRBS United States
  • Employees
  • ITOS N/A
  • BRBS N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • BRBS Commercial Banks
  • Sector
  • ITOS Health Care
  • BRBS Finance
  • Exchange
  • ITOS Nasdaq
  • BRBS Nasdaq
  • Market Cap
  • ITOS 270.7M
  • BRBS 272.1M
  • IPO Year
  • ITOS 2020
  • BRBS N/A
  • Fundamental
  • Price
  • ITOS $9.99
  • BRBS $3.31
  • Analyst Decision
  • ITOS Hold
  • BRBS
  • Analyst Count
  • ITOS 6
  • BRBS 0
  • Target Price
  • ITOS $10.60
  • BRBS N/A
  • AVG Volume (30 Days)
  • ITOS 1.8M
  • BRBS 224.1K
  • Earning Date
  • ITOS 08-07-2025
  • BRBS 07-24-2025
  • Dividend Yield
  • ITOS N/A
  • BRBS N/A
  • EPS Growth
  • ITOS N/A
  • BRBS N/A
  • EPS
  • ITOS N/A
  • BRBS N/A
  • Revenue
  • ITOS $35,000,000.00
  • BRBS $90,259,000.00
  • Revenue This Year
  • ITOS N/A
  • BRBS N/A
  • Revenue Next Year
  • ITOS N/A
  • BRBS N/A
  • P/E Ratio
  • ITOS N/A
  • BRBS N/A
  • Revenue Growth
  • ITOS 177.89
  • BRBS N/A
  • 52 Week Low
  • ITOS $4.80
  • BRBS $2.45
  • 52 Week High
  • ITOS $18.13
  • BRBS $3.83
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 65.96
  • BRBS 39.67
  • Support Level
  • ITOS $9.93
  • BRBS $3.29
  • Resistance Level
  • ITOS $10.21
  • BRBS $3.38
  • Average True Range (ATR)
  • ITOS 0.18
  • BRBS 0.07
  • MACD
  • ITOS -0.11
  • BRBS -0.02
  • Stochastic Oscillator
  • ITOS 18.07
  • BRBS 15.56

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.

Share on Social Networks: